Table 1.

Demographic characteristics, etiology, management, and outcomes of patients with vancomycin-resistant endophthalmitis due to Gram-positive bacteria

Serial number	Age (years)	Sex	Etiology	Duration (days)	Presenting V/A	Primary intervention	Secondary intervention	Smear	Systemic antibiotic	Intravitreal antibiotic	Intravitreal steroid	Final V/A	Follow-up (months)	Outcome
1	20	M	Trauma	1	LP	CTR + PPV + IOAB	PPV + M + C + T	GPB	Ciprofloxacin	V + C	T	CF - 1 m	3	Unfavorable
2	70	F	Postcataract surgery	5	LP	PPV + IOAB + IOL explant	Nil	GPC	Gatifloxacin	V + A	D	LP	3	Unfavorable
3	70	M	Postcataract surgery	1	LP	PPV + IOAB	C + T	GPB	Ciprofloxacin	V + A	T	20/20p	4	Favorable
4	5	M	Trauma	1	LP	CTR + PPL + PPV + IOAB	Nil	GPB	Cephalexin	V + C + Am	-	LP	6	Unfavorable
5	4	F	Trauma	3	HM	CTR + PPL + PPV + IOAB	Nil	GPB	Ciprofloxacin	V + C	-	LP	3	Unfavorable
6	60	M	Postcataract surgery	6	LP	PPV + IOAB	Nil	GPC	Ciprofloxacin	V + C	-	LP	6	Unfavorable
7	16	F	Endogenous	20	LP	PPV + IOAB	Enucleation	GPC	Ciprofloxacin	V + A	-	NLP	6	Unfavorable

C, ceftazidime; T, triamcinolone; D, dexamethasone; V, vancomycin; A, amikacin; M, membranectomy; GPC, Gram-positive cocci; GPB, Gram-positive bacilli; CTR, corneal tear repair; PPV, pars plana vitrectomy; IOAB, intraocular antibiotic; PPL, pars plana lensectomy; Am, amphotericin B; CF, counting fingers; LP, light perception; NLP, no light perception; V/A, visual acuity.